Food and Drug Administration approved SYMDEKO for use in children with cystic fibrosis ages 6 through 11 years who have two copies of the F508del-CFTR mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator gene
that is responsive to SYMDEKO.
The United States Food and Drug Administration (FDA) has approved United States-based Vertex Pharmaceuticals Incorporated's (Nasdaq:VRTX) KALYDECO (ivacaftor) intended for use in children with cystic fibrosis (CF) aged six months to less than 12 months who have at least one mutation in their cystic fibrosis transmembrane conductance regulator gene
that is responsive to KALYDECO based on clinical and/or in vitro assay data, it was reported yesterday.
A CF transmembrane conductance regulator gene
library was constructed using the Nextflex Cystic Fibrosis Amplicon Panel (Austin, Texas) according to the manufacturer's instructions.
coelicolor genome 67 are located in pair with their cognate response regulator gene
and 17 genes were identified as orphan (53).
Novel mutations of the autoimmune regulator gene
in two siblings with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
Howie, "A comparative study of mRNA and protein expression of the autoimmune regulator gene
(Aire) in embryonic and adult murine tissues," Journal of Pathology, vol.
Mieusset, "Congenital bilateral absence of the vas deferens: clinical characteristics, biological parameters, cystic fibrosis transmembrane conductance regulator gene
mutations, and implications for genetic counseling," Fertility and Sterility, vol.
Cystic fibrosis transmembrane conductance regulator gene
abnormalities in patients with asthma and recurrent neutrophilic bronchitis.
DNA from 359 ESBL isolates (4) was screened for the presence of the EAEC transport regulator gene
(aggR), located on the EAEC plasmid, by using a real-time PCR assay and the following primers and probe: AggR F 5'-CCATTTATCGCAATCAGATTAA-3' AggRR 5'-CAAGCATCTACTTTTGATATTCC-3 AggR_P Cy5-CAGCGATACATTAAGACGCCTAAAGGA-BHQ.
Written and edited by professional experts, MYC and the Pathway to Cancer is a scholarly text about the regulator gene
Relation between the anatomical genital phenotype and cystic fibrosis transmembrane conductance regulator gene
mutations in the absence of the vas deferens.